No Detail Found!

Hepatotoxic Effects Induced by a Traditional Oral Anti-hyperglycemic Drug in Healthy Mice.

Author(s)
Shagufta Andleeb Department of Zoology, Division of Science & Technology, University of Education, College Road, Lahore,
SHABANA SHAUKAT Department of Zoology, Division of Science & Technology, University of Education, College Road, Lahore,
SIDRA NAWAZ Department of Zoology, New Campus, University of the Punjab, Lahore,
Abstract
Metformin is an oral anti hyperglycemic drug used by the patients of diabetes all over the world. In present study, Metformin hydrochloride (Glucophage) was used to determine the histological changes in liver of mice. Twenty mice (4-5 weeks old) were given oral gavages of 0.1 ml of 0.00, 31.25, 125 and 500µg/g B.W (Complete). of Metformin prepared in distilled water, for 04 weeks daily. After 24 hours of last dose, the animals were anaesthetized torecoverliver tissues following fixation in Bouin's fluid and processing for histological preparation using different grades of alcohol and xylene for dehydration. These tissues were later on infiltrated with paraffin wax, sectioned to size of 4µm and stained with Hematoxylin and Eosin. The histological analysis revealed that metformin could cause adverse malformations like pyknosis, necrosis, and steatosis.
Publication Details
Page(s) 1-6
DOI DOI not available
Published Journal: Biologia, Volume: 64, Issue: 1, Year: 2018

Request the full text from PASTIC

References
Abdelsatir , A. A.,Husain , N. E.,Hassan , A. T.,Elmadhoun , W. M.,Almobarak , A. O.,Ahmed , M. H., 2015.Potential Benefit of Metformin as Treatment for Colon Cancer: the Evidence so Far,Asian Pac. J. Cancer Prev 16 8053 -8058
Al-Wahab , Z.,Mert , I.,Tebbe , C.,Chhina , J.,Hijaz , M.,Morris,Ali-Fehmi , R.,Giri , S.,Munkarah , A. R.,Rattan , R., 2015.Metformin prevents aggressive ovarian cancer growth driven by highenergy diet: similarity with calorie restriction,Oncotarget. 6 10908 -10923
Argun , M.,Uzum , K.,Sonmez , M. F.,Ozyurt , A.,Karabulut , D.,Soyersarica , Z.,Cilenk , K. T.,Unalmis , S.,Pamukcu , O.,Baykan , A.,Narin , F.,Elmali , F.,Narin , N., 2015.Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats,Anatol. J. Cardiol. 16 234 -241
Balogh , Z.,Matyus , J., 2012.Proposal for the modification of metformin use in patients with chronic kidney disease,Orv. Hetil. 153 1527 -1535
Bergheim , I.,Luyendyk , J. P.,Steele , C.,Russell , G. K.,Guo , L.,Roth , R. A.,Arteel , G.E., 2006.Metformin prevents endotoxin-induced liver injury after partial hepatectomy,J. Pharmacol. Exp. Ther. 316 1053 -1061
Bhat , A.,Sebastiani , G.,Bhat , M., 2015.Systematic review: Preventive and therapeutic applications of metformin in liver disease,World J. Hepatol. 7 1652 -1659
Cahova , M.,Palenickova , E.,Dankova , H.,Sticova , E.,Burian , M.,Drahota , Z.,Cervinkova , Z.,Kucera , O.,Gladkova , C.,Stopka , P.,Krizova , J.,Papackova , Z.,Oliyarnyk , O.,Kazdova , L., 2015.Metformin prevents ischemia reperfusion-induced oxidative stress in the fatty liver by attenuation of reactive oxygen species formation,Am. J. Physiol Gastrointest. Liver Physiol 309 100 -111
Cao , J.,Meng , S.,Chang , E.,Beckwith-Fickas , K.,Xiong , L.,Cole , R.N.,Radovick , S.,Wondisford , F.E.,He , L., 2014.Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK),J. Biol. Chem 289 20435 -20446
Chu , C. K.,Chang , Y. T.,Lee , B. J.,Hu , S. Y.,Hu , W. H.,Yang , D. Y., 2003.Metformin-associated lactic acidosis and acute renal failure in a type 2 diabetic patient,J. Chin. Med 66 505 -508
Conde,Vrenken , T.E.,Buist-Homan , M.,Faber , K.N.,Moshage , H., 2015.Metformin protects primary rat hepatocytes against oxidative stressinduced apoptosis,Pharmacol. Res. Perspect. 3 e00125 -
Cone , C.J.,Bachyrycz , A.M.,Murata , G.H., 2010.Hepatotoxicity associated with metformin therapy in treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease, 44 1655 -1659
Decker , S.O.,Wortmann , M.,Siegler , B.H.,Ulrich , A.,Hofer , S.,Brenner , T., 2015.Metformin-induced lactic acidosis : Severe symptoms with difficult diagnostics,Anaesthesist 64 292 -297
DeFronzo , R.,Fleming , G.A.,Chen , K.,Bicsak , T.A., 2016.Metformin-associated lactic acidosis: Current perspectives on causes and risk,Metabolism 65 20 -29
Fu , L.,Bruckbauer , A.,Li , F.,Cao , Q.,Cui , X.,Wu , R.,Shi , H.,Zemel , M.B.,Xue , B., 2015.Interaction between metformin and leucine in reducing hyperlipidemia and hepatic lipid accumulation in diet-induced obese mice,Metabolism 64 1426 -1434
Garofalo , C.,Iazzetta , N.,Camocardi , A.,Pacilio , M.,Iodice , C.,Minutolo , R.,N. L. & Conte,G., 2015.Anti-diabetics and chronic kidney disease, 32 -
Guo , Q.,Liu , Z.,Jiang , L.,Liu , M.,Ma , J.,Yang , C.,Han , L.,Nan , K.,Liang , X., 2016.Metformin inhibits growth of human nonsmall cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase,Mol. Med 13 2590 -2596
Hivert , M.F.,Christophi , C.A.,Franks , P.W.,Jablonski , K.A.,Ehrmann , D.A.,Kahn , S. E.,Horton , E.S.,Pollin , T.I.,Mather , K.J.,Perreault , L.,Barrett-Connor , E.,Knowler , W.C.,Florez , J.C., 2016.Lifestyle and Metformin Ameliorate Insulin Sensitivity Independently of the Genetic Burden of Established Insulin Resistance Variants in Diabetes Prevention Program Participants, 65 520 -526
Hostalek , U.,Gwilt , M.,Hildemann , S., 2015.Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention, 75 1071 -1094
Ismail , T. A.,Soliman , M. M.,Nassan , M. A., 2015.Molecular and immunohistochemical effects of metformin in a rat model of type 2 diabetes mellitus,Exp. Ther. Med 1921 -1930
Kutoh , E., 2005.Possible metformin-induced hepatotoxicity,Am. J. Geriatr. Pharmacother. 3 270 -273
Linden , M. A.,Lopez , K. T.,Fletcher , J. A.,Morris , E. M.,Meers , G. M.,Siddique , S.,Laughlin , M. H.,Sowers , J. R.,Thyfault , J. P.,Ibdah , J. A.,Rector , R. S., 2015.Combining metformin therapy with caloric restriction for the management of type 2 diabetes and nonalcoholic fatty liver disease in obese rats,Appl. Physiol. Nutr 40 1038 -1047
Ling , S.,Tian , Y.,Zhang,Jia , K.,Feng , T.,Sun , D.,Gao , Z.,Xu , F.,Hou , Z.,Li , Y.,Wang , L., 2014.Metformin reverses multidrug resistance in human hepatocellular carcinoma Bel7402/5 fluorouracil cells,Mol. Med 10 2891 -2897
Lovas , K.,Fadnes , D. J.,Dale , A., 2000.Metformin associated lactic acidosis-- case reports and literature review,Tidsskr. Nor Laegeforen 120 1539 -1541
Madiraju , A. K.,Erion , D. M.,Rahimi , Y.,Zhang , X. M.,Braddock , D. T.,Albright , R. A.,Prigaro , B. J.,Wood , J. L.,Bhanot , S.,Jurczak , M. J.,Camporez , J. P.,Lee , H. Y.,Cline , G. W.,Samuel , V. T.,Kibbey , R. G.,Shulman , G. I., 2014.Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase,Nature 510 542 -546
Malin , S. K.,Kashyap , S. R., 2014.Effects of metformin on weight loss: potential mechanisms,Curr. Opin. Endocrinol. Diabetes Obes. 21 323 -329
Meng , S.,Cao , J.,He , Q.,Xiong , L.,Chang , E.,Radovick , S.,Wondisford , F. E.,He , L., 2015.Metformin activates AMP-activated protein kinase by promoting formation of the alphabetagamma heterotrimeric complex,J.Biol. Chem 290 3793 -3802
Othman , E. M.,Oli , R. G.,Arias-Loza , P. A.,Kreissl , M. C.,Stopper , H., 2016.Metformin Protects Kidney Cells From Insulin-Mediated Genotoxicity In Vitro and in Male Zucker Diabetic Fatty Rats, 157 548 -559
Pilmore , H. L., 2010.Review: metformin: potential benefits and use in chronic kidney disease,Nephrol. 15 412 -418
Qu , H.,Yang , X., 2015.Metformin inhibits angiogenesis induced by interaction of hepatocellular carcinoma with hepatic stellate cells,Cell Biochem 71 931 -936
Rafieian-Kopaei , M.,Baradaran , A.,Merrikhi , A.,Nematbakhsh , M.,Madihi , Y.,Nasri , H., 2013.Efficacy of Co-administration of Garlic Extract and Metformin for Prevention of Gentamicin-Renal Toxicity in Wistar Rats: A Biochemical Study,Int. J. Prev. Med 4 258 -264
Reeker , W.,Schneider , G.,Felgenhauer , N.,Tempel , G.,Kochs , E., 2000.Metformininduced lactic acidosis,Dtsch. Med 125 249 -251
Saadi , T.,Waterman , M.,Yassin , H.,Baruch , Y., 2013.Metformin-induced mixed hepatocellular and cholestatic hepatic injury: case report and literature review,Int. J. Gen. Med 6 703 -706
Senesi , P.,Montesano , A.,Luzi , L.,Codella , R.,Benedini , S.,Terruzzi , I., 2016.Metformin Treatment Prevents Sedentariness Related Damages in Mice,J. Diabetes Res. 8274689 -
Sheta , A.,Elsakkar , M.,Hamza , M.,Solaiman , A., 2016.Effect of metformin and sitagliptin on doxorubicin-induced cardiotoxicity in adult male albino rats,Hum. Exp. Toxicol. 35 1227 -1239
Song , Y. M.,Lee , Y. H.,Kim , J. W.,Ham , D. S.,Kang , E. S.,Cha , B. S.,Lee , H. C.,Lee , B. W., 2015.Metformin alleviates hepatosteatosis by restoring SIRT1- mediated autophagy induction via an AMP-activated protein kinaseindependent pathway,Autophagy 11 46 -59
Sosnicki , S.,Kapral , M.,Weglarz , L., 2016.Molecular targets of metformin antitumor action,Pharmacol. Rep 68 918 -925
Subhasree , N.,Kamella , A.,Kaliappan , I.,Agrawal , A.,Dubey , G. P., 2015.Antidiabetic and antihyperlipidemic activities of a novel polyherbal formulation in high fat diet/streptozotocin induced diabetic rat model,Indian J. Pharmacol. 47 509 -513
Tan , S.,Vollmar , N.,Benson , S.,Sowa , J. P.,Bechmann , L. P.,Gerken , G.,Fuhrer , D.,Canbay , A., 2015.Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome,Int. J. Endocrinol. 254169 -
Tseng , C. H., 2016.Use of metformin and risk of kidney cancer in patients with type 2 diabetes,Eur. J. Cancer 52 19 -25
Viollet , B.,Guigas , B.,Sanz , G. N.,Leclerc , J.,Foretz , M.,Andreelli , F., 2012.Cellular and molecular mechanisms of metformin: an overview,Clin. Sci. (Lond) 122 253 -270
Wang , Z. S.,Liu , X. H.,Wang , M.,Jiang , G. J.,Qiu , T.,Chen , Z. Y.,Wang , L., 2015.Metformin attenuated the inflammation after renal ischemia/reperfusion and suppressed apoptosis of renal tubular epithelial cell in rats,Acta Cir 30 617 -623
Yang , X.,Sun , D.,Tian , Y.,Ling , S.,Wang , L., 2015.Metformin sensitizes hepatocellular carcinoma to arsenic trioxide-induced apoptosis by downregulating Bcl2 expression, 36 2957 -2964
Zheng , J.,Woo , S. L.,Hu , X.,Botchlett , R.,Chen , L.,Huo , Y.,Wu , C., 2015.Metformin and metabolic diseases: a focus on hepatic aspects, -
Zhong , Z. H.,Zhong , Z. Y.,Zhu , Z. T.,Li , C.,Zhang,Tong , M.,Jiang , H. M., 2015.Effect of metformin on the proliferation and apoptosis of the renal cancer cell line 786-O and the underlying mechanisms,J.Buon. 20 1244 -1249
0

Citations

0

Downloads

48

Views